FUT2 W143X — Secretor Status and the Gateway to Your Gut
The FUT2 gene encodes fucosyltransferase 2 | An enzyme that adds fucose sugar
residues to glycan chains on cell surfaces and in secreted mucus, an enzyme
that determines one of the most fundamental divisions in human biology: whether
you are a "secretor" or a "non-secretor." Secretors express
ABO blood group antigens | The same A, B, and H antigens that define your blood
type (A, B, AB, O), but expressed on mucosal surfaces and in saliva, tears,
breast milk, and intestinal mucus rather than just on red blood cells
on their mucosal surfaces and in bodily fluids like saliva and intestinal mucus.
Non-secretors do not.
A single G-to-A change at position 428 of the FUT2 coding sequence creates a
premature stop codon (Trp143Ter), completely inactivating the enzyme. People
with two copies of the A allele — about 20% of Europeans — produce no functional
FUT2 and are non-secretors. This is one of the most pleiotropic | Affecting
multiple, seemingly unrelated traits from a single genetic variant common
variants in the human genome, influencing gut microbiome composition, vitamin B12
metabolism, susceptibility to viral infections, and risk of autoimmune disease.
The Mechanism
FUT2 adds fucose | A six-carbon sugar (6-deoxy-L-galactose) that serves as a
building block for complex sugar chains on cell surfaces to glycan structures
on the intestinal epithelium and in mucosal secretions, creating the H antigen —
the precursor to A and B blood group antigens. In secretors, these fucosylated
glycans coat the gut lining and are shed into the intestinal lumen, where they
serve two critical functions.
First, they act as attachment points for certain pathogens. Norovirus and
rotavirus bind to H-type and Lewis blood group antigens on intestinal cells to
initiate infection. Without these glycans, the viruses literally cannot gain
a foothold. Second, the shed fucosylated glycans serve as a carbon source for
beneficial gut bacteria, particularly Bifidobacterium | A genus of beneficial
bacteria that are among the first colonizers of the infant gut and remain
important for intestinal health throughout life species, which have evolved
specialized enzymes to harvest fucose from host glycans.
The W143X nonsense mutation truncates the FUT2 protein at amino acid 143 (of 332
total), eliminating the catalytic domain entirely. Heterozygous carriers (AG)
retain secretor status because one functional copy produces sufficient enzyme,
though possibly at somewhat reduced levels.
The Evidence
The landmark norovirus study | Thorven M et al. A homozygous nonsense
mutation (428G→A) in the human secretor (FUT2) gene provides resistance to
symptomatic norovirus (GGII) infections. J Virol, 2005
demonstrated that among 115 Swedish adults exposed to norovirus outbreaks,
not a single non-secretor (AA genotype) developed symptomatic infection, while
49% of GG homozygotes and 51% of AG heterozygotes were affected. A
2021 meta-analysis of 20 studies | Bustamante M et al. FUT2 and norovirus:
a systematic review and meta-analysis
confirmed that non-secretors are approximately 3 times more likely to remain
uninfected during norovirus exposure.
For vitamin B12, a genome-wide association study | Hazra A et al. Common
variants of FUT2 are associated with plasma vitamin B12 levels. Nat Genet,
2008 identified FUT2 as the
strongest genetic determinant of plasma B12 levels (p = 5.36 x 10-17).
Paradoxically, non-secretors have 16-18% higher measured serum B12 | Velkova A
et al. The FUT2 secretor variant p.Trp154Ter influences serum vitamin B12
concentration via holo-haptocorrin. Hum Mol Genet, 2017.
However, this elevation is in
haptocorrin-bound B12 | Haptocorrin (also called transcobalamin I) is a B12
carrier protein in blood that is not readily taken up by cells. It is distinct
from transcobalamin II, which delivers B12 to tissues
— a biologically inactive fraction — rather than in
holotranscobalamin | The portion of blood B12 bound to transcobalamin II, which
is the only form that can be actively taken up by cells and used for metabolic
reactions, the bioavailable form. This means standard total B12 blood tests
may overestimate functional B12 status in non-secretors.
The Crohn's disease link | McGovern DPB et al. Fucosyltransferase 2 (FUT2)
non-secretor status is associated with Crohn's disease. Hum Mol Genet,
2010 was established through GWAS,
with non-secretors showing increased susceptibility (OR ~1.64 for AA genotype).
A separate study | Smyth DJ et al. FUT2 nonsecretor status links type 1
diabetes susceptibility and resistance to infection. Diabetes,
2011 found that the AA genotype
also confers susceptibility to type 1 diabetes (OR 1.29, 95% CI 1.20-1.37,
p = 4.3 x 10-18). The proposed mechanism links altered gut microbiome
composition to immune dysregulation.
The gut microbiome connection | Wacklin P et al. Secretor genotype (FUT2 gene)
is strongly associated with the composition of bifidobacteria in the human
intestine. PLoS One, 2011
showed that non-secretors harbor significantly lower diversity and abundance of
Bifidobacterium species. Without fucosylated glycans lining the gut, these
beneficial bacteria lose a primary food source, potentially contributing to
the gut dysbiosis that underlies the increased Crohn's and autoimmune risk.
Practical Implications
The effects of FUT2 secretor status are a striking example of evolutionary
trade-offs. Non-secretors gain robust protection against norovirus (and likely
rotavirus and some bacterial pathogens) at the cost of a less diverse gut
microbiome and modestly increased risk of certain autoimmune conditions.
For non-secretors (AA), the most actionable implications involve gut health
maintenance and vitamin B12 monitoring. Since standard serum B12 tests may be
misleadingly normal, requesting a holotranscobalamin (active B12) or
methylmalonic acid test provides a more accurate picture of functional B12 status.
Supporting gut bifidobacterial populations through targeted probiotics and
prebiotic fiber is also worth considering, given the reduced diversity seen in
non-secretors.
For heterozygous carriers (AG), secretor function is preserved and no specific
action is typically needed, though being aware of this variant's role in B12
metabolism can inform supplement choices.
Interactions
FUT2 secretor status interacts with ABO blood type. The A and B antigens are
built on top of the H antigen that FUT2 creates — so non-secretors do not
express A, B, or H antigens in their mucus regardless of their ABO blood type.
This means ABO-mediated disease associations on mucosal surfaces (such as
susceptibility to H. pylori) can be modified by FUT2 status.
The variant rs602662 (S258G) and rs492602 are in strong linkage disequilibrium
with rs601338 and show similar associations with B12 levels and disease risk.
In East Asian populations, a different FUT2 variant (rs1047781, A385T) is the
primary determinant of secretor status, since the W143X variant is nearly absent
in that population (allele frequency <0.2%).
All Genotypes
Full secretor — normal FUT2 function and mucosal antigen expression
You carry two functional copies of the FUT2 gene (GG genotype). You are a secretor, meaning your body expresses ABO blood group antigens on mucosal surfaces and in saliva, tears, breast milk, and intestinal mucus. This is the most common genotype, shared by about 29% of people globally and 26% of Europeans. Your gut lining produces fucosylated glycans that nourish beneficial Bifidobacterium species, supporting a diverse intestinal microbiome. Your standard serum vitamin B12 tests accurately reflect your functional B12 status. However, you have no genetic protection against norovirus — this is the ancestral state with normal susceptibility to gut infections.
Non-secretor — no FUT2 function, altered gut microbiome and B12 metabolism
You carry two copies of the A allele (AA genotype), making you a non-secretor. Your body does not express ABO blood group antigens on mucosal surfaces or in bodily fluids. About 20% of Europeans and Africans share this genotype, while it is extremely rare in East Asians (<0.1%). This has several significant effects: you have strong natural resistance to norovirus and rotavirus infections, but your gut microbiome has reduced Bifidobacterium diversity. Your standard serum B12 tests may overestimate your functional B12 levels, and you have a modestly increased risk of Crohn's disease and type 1 diabetes.
Secretor with one non-secretor allele — normal function, carrier status
You carry one functional G allele and one non-functional A allele (AG heterozygote). Because secretor status is a recessive trait, one working copy of FUT2 is sufficient to maintain full secretor function. You express ABO blood group antigens normally on mucosal surfaces. This is the most common genotype worldwide — about 50% of Europeans carry it. Your gut microbiome, vitamin B12 metabolism, and infection susceptibility are essentially identical to the GG genotype. You are a carrier of the non-secretor allele and could pass it to your children.